Comparison of the bactericidal activities and post-antibiotic effects of the des-F(6)-quinolone BMS-284756, levofloxacin, and ciprofloxacin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 21, Issue 1, 2002, Pages 27-34

  Ryan, B ^a   Mazzucco, C ^a   Lawrence, L ^a   Ho, H ^a   Warr, G ^a   Barrett, J ^b   Frosco, M ^a  

^a BRISTOL MYERS SQUIBB   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; GARENOXACIN; LEVOFLOXACIN; METICILLIN;

ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG SCREENING; KINETICS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ANTI-INFECTIVE AGENTS; BLOOD BACTERICIDAL ACTIVITY; CIPROFLOXACIN; DRUG RESISTANCE, MICROBIAL; FLUOROQUINOLONES; HUMANS; INDOLES; METHICILLIN; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; OFLOXACIN; QUINOLONES; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS AUREUS;

EID: 0036174742     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100960100624     Document Type: Article

References (22)

1. In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinolone
2. Antibacterial spectrum of a novel des-fluoro(6)quinolone, BMS-284756
3. Selection and characterization of BMS-284756-resistant mutants in Streptococcus pneumoniae
4. Bactericidal properties of moxifloxacin and post-antibiotic effect
5. Postantibiotic effect
6. Comparison of the postantibiotic and postantibiotic sub-MIC effects of levofloxacin and ciprofloxacin on Staphylococcus aureus and Streptococcus pneumoniae
7. In vitro models for prediction of antimicrobial activity: A pharmacokinetic and pharmacodynamic perspective
8. Achieving an optimal outcome in the treatment of infections: The role of clinical pharmacokinetics and pharmacodynamics of antimicrobials
9. Postantibiotic effects of grepafloxacin compared to those of five other agents against 12 gram-positive and -negative bacteria
10. Susceptibility testing of antimicrobials in liquid media
11. Antimicrobial combinations
12. The estimation of biomass
13. A new method to determine postantibiotic effect and effects of subinhibitory antibiotic concentrations
14. Safety and pharmacokinetics of multiple 750-milligram doses of intravenous levofloxacin in healthy volunteers
15. Safety, tolerability, and pharmacokinetics of BMS-284756, a novel des-F(6)-quinolone, following 14-day oral doses in healthy adult subjects
16. Postantibiotic effect of DU-6859a and levofloxacin as compared with ofloxacin
17. The post-antibiotic sub-MIC effect in vitro and in vivo
18. Basis of anti-infective therapy: Pharmacokinetic-pharmacodynamic criteria and methodology for dual dosage individualisation
19. Sitafloxacin (DU-6859a) and trovafloxacin: Postantibiotic effect and in vitro interactions with rifampin on methicillin-resistant Staphylococcus aureus
20. Postantibiotic effects of gatifloxacin against gram-positive and -negative organisms